Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A14164 | 29556346 | Theranostics | Non-Invasive Electrical Impedance Tomography for Multi-Scale Detection of Liver Fat Content. | 2018 | Details |
| A14165 | 29556076 | Sci Rep | The Nuclear Orphan Receptor Nur77 Alleviates Palmitate-induced Fat Accumulation by Down-regulating G0S2 in HepG2 Cells. | 2018 | Details |
| A14166 | 29555959 | Sci Rep | Waist circumference is a mediator of dietary pattern in Non-alcoholic fatty liver disease. | 2018 | Details |
| A14167 | 29555681 | J Biol Chem | Patatin-like phospholipase domain–containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets. | 2018 | Details |
| A14168 | 29555504 | Eur J Pharmacol | Alantolactone suppresses APOC3 expression and alters lipid homeostasis in L02 liver cells. | 2018 | Details |
| A14169 | 29555473 | Biochem Biophys Res Commun | Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis. | 2018 | Details |
| A14171 | 29553485 | J Clin Invest | Aortic carboxypeptidase-like protein, a WNT ligand, exacerbates nonalcoholic steatohepatitis. | 2018 | Details |
| A14172 | 29552625 | Cell Mol Gastroenterol Hepatol | Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2). | 2017 | Details |
| A14173 | 29552621 | Cell Mol Gastroenterol Hepatol | Ferroportin Expression in Adipocytes Does Not Contribute to Iron Homeostasis or Metabolic Responses to a High Calorie Diet. | 2018 | Details |
| A14174 | 29552373 | Liver Res | Decoding the Role of Extracellular Vesicles in Liver Diseases. | 2017 | Details |
| A14175 | 29551054 | Korean J Intern Med | Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis. | 2018 | Details |
| A14176 | 29550812 | Cell Physiol Biochem | Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A14177 | 29550470 | Biochem Biophys Res Commun | PPARγ alleviated hepatocyte steatosis through reducing SOCS3 by inhibiting JAK2/STAT3 pathway. | 2018 | Details |
| A14179 | 29549269 | Sci Rep | Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study. | 2018 | Details |
| A14180 | 29548345 | BMC Pharmacol Toxicol | A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis. | 2018 | Details |
| A14181 | 29547708 | Atherosclerosis | Resolution of fatty liver and weight loss: Independent associations with changes in serum lipids and apolipoproteins. | 2018 | Details |
| A14182 | 29547706 | Atherosclerosis | Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors. | 2018 | Details |
| A14183 | 29547047 | Endocr Pract | PEDIATRIC VISCERAL ADIPOSITY INDEX ADAPTATION CORRELATES WITH HOMA-IR, MATSUDA, AND TRANSAMINASES. | 2018 | Details |
| A14185 | 29545896 | Exp Ther Med | Influence of different concentrations of uric acid on oxidative stress in steatosis hepatocytes. | 2018 | Details |
| A14186 | 29544992 | Mol Aspects Med | Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action. | 2018 | Details |
| A14187 | 29542003 | J Nat Med | Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway. | 2018 | Details |
| A14188 | 29540533 | Biosci Rep | Serum, liver and bile sitosterol and sitostanol in obese patients with and without NAFLD. | 2018 | Details |
| A14190 | 29538359 | Pediatr Res | Gut microbiota in adolescents and the association with fatty liver: the EPOCH study. | 2018 | Details |
| A14191 | 29537411 | J R Coll Physicians Edinb | Bariatric surgery as a treatment for metabolic syndrome. | 2017 | Details |
| A14192 | 29536744 | Bratisl Lek Listy | The relationship between hepatocytes and small bowel after early and short food restriction: What the results show in morphometry. | 2018 | Details |
| A14195 | 29534506 | Nutrients | Saccharin Increases Fasting Blood Glucose but Not Liver Insulin Resistance in Comparison to a High Fructose-Fed Rat Model. | 2018 | Details |
| A14198 | 29531463 | World J Gastroenterol | Autophagy activation by Jiang Zhi Granule protects against metabolic stress-induced hepatocyte injury. | 2018 | Details |
| A14199 | 29531278 | Sci Rep | Author Correction: Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism. | 2018 | Details |
| A14200 | 29529073 | PLoS One | Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort. | 2018 | Details |
| A14201 | 29527789 | Diabetes Obes Metab | Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2018 | Details |
| A14202 | 29527259 | World J Hepatol | Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research. | 2018 | Details |
| A14203 | 29527255 | World J Hepatol | Glycogenic hepatopathy: A narrative review. | 2018 | Details |
| A14204 | 29527224 | Gastroenterol Res Pract | Association between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease: A Single-Center Clinical Study. | 2018 | Details |
| A14205 | 29527140 | Clin Proteomics | Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A14206 | 29526820 | Biochim Biophys Acta Mol Basis Dis | Benzbromarone aggravates hepatic steatosis in obese individuals. | 2018 | Details |
| A14207 | 29526751 | Biochem Biophys Res Commun | Enoyl coenzyme A hydratase 1 protects against high-fat-diet-induced hepatic steatosis and insulin resistance. | 2018 | Details |
| A14210 | 29525610 | Nutr Res | Arctigenin protects against steatosis in WRL68 hepatocytes through activation of phosphoinositide 3-kinase/protein kinase B and AMP-activated protein kinase pathways. | 2018 | Details |
| A14211 | 29524401 | Biochem Biophys Res Commun | Ablation of prolactin receptor increases hepatic triglyceride accumulation. | 2018 | Details |
| A14212 | 29523931 | Arch Toxicol | In utero and lactational exposure to BDE-47 promotes obesity development in mouse offspring fed a high-fat diet: impaired lipid metabolism and intestinal dysbiosis. | 2018 | Details |
| A14214 | 29523305 | Med Hypotheses | Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis. | 2018 | Details |
| A14215 | 29523084 | BMC Genomics | A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis. | 2018 | Details |
| A14216 | 29522534 | PLoS One | Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease. | 2018 | Details |
| A14217 | 29520889 | Phytother Res | Efficacy of artichoke leaf extract in non-alcoholic fatty liver disease: A pilot double-blind randomized controlled trial. | 2018 | Details |
| A14218 | 29519663 | Surg Obes Relat Dis | Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease? | 2017 | Details |
| A14219 | 29519502 | Lancet | NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. | 2018 | Details |
| A14221 | 29519316 | Phytomedicine | CGplus, a standardized herbal composition ameliorates non-alcoholic steatohepatitis in a tunicamycin-induced mouse model. | 2018 | Details |
| A14222 | 29517842 | Liver Int | Serum testosterone and non-alcoholic fatty liver disease in men and women in the US. | 2018 | Details |
| A14223 | 29517271 | Biomark Med | The search for noninvasive methods to identify liver fibrosis in children with nonalcoholic fatty liver disease. | 2018 | Details |
| A14224 | 29516496 | J Physiol | Primate fetal hepatic responses to maternal obesity: epigenetic signalling pathways and lipid accumulation. | 2018 | Details |
| A14225 | 29516226 | Eur J Nutr | Chronic fructose intake does not induce liver steatosis and inflammation in female Sprague-Dawley rats, but causes hypertriglyceridemia related to decreased VLDL receptor expression. | 2018 | Details |
| A14226 | 29515630 | Iran J Pathol | Clinical Manifestations and Diagnosis of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A14227 | 29515134 | Sci Rep | Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux. | 2018 | Details |
| A14228 | 29515023 | JCI Insight | LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity. | 2018 | Details |
| A14229 | 29514661 | J Transl Med | Physiological and molecular effects of interleukin-18 administration on the mouse kidney. | 2018 | Details |
| A14230 | 29514047 | Biochim Biophys Acta Mol Basis Dis | Deletion of NLRX1 increases fatty acid metabolism and prevents diet-induced hepatic steatosis and metabolic syndrome. | 2018 | Details |
| A14234 | 29512720 | Mol Med Rep | Alogliptin alleviates hepatic steatosis in a mouse model of nonalcoholic fatty liver disease by promoting CPT1a expression via Thr172 phosphorylation of AMPKα in the liver. | 2018 | Details |
| A14235 | 29511882 | Curr Atheroscler Rep | Cardiometabolic Effects of Anti-obesity Pharmacotherapy. | 2018 | Details |
| A14236 | 29511669 | Biomed Res Int | Ethanol Extract from Ulva prolifera Prevents High-Fat Diet-Induced Insulin Resistance, Oxidative Stress, and Inflammation Response in Mice. | 2018 | Details |
| A14237 | 29511346 | Oncogene | Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer. | 2018 | Details |
| A14238 | 29510489 | Int J Mol Sci | Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease. | 2018 | Details |
| A14239 | 29509992 | Liver Int | Unanticipated increases in hepatic steatosis among human immunodeficiency virus patients receiving mineralocorticoid receptor antagonist eplerenone for non-alcoholic fatty liver disease. | 2018 | Details |
| A14240 | 29509436 | Am J Physiol Endocrinol Metab | Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. | 2018 | Details |
| A14241 | 29508520 | Mol Nutr Food Res | Sugary Kefir Strain Lactobacillus mali APS1 Ameliorated Hepatic Steatosis by Regulation of SIRT-1/Nrf-2 and Gut Microbiota in Rats. | 2018 | Details |
| A14242 | 29508519 | Mol Nutr Food Res | Caffeic Acid Phenethyl Ester Improves Metabolic Syndrome by Activating PPAR-γ and Inducing Adipose Tissue Remodeling in Diet-Induced Obese Mice. | 2018 | Details |
| A14243 | 29507903 | Hepatol Commun | Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease. | 2018 | Details |
| A14244 | 29507902 | Hepatol Commun | Vinyl chloride dysregulates metabolic homeostasis and enhances diet-induced liver injury in mice. | 2018 | Details |
| A14245 | 29507693 | Oncotarget | Copper/MYC/CTR1 interplay: a dangerous relationship in hepatocellular carcinoma. | 2018 | Details |
| A14246 | 29507274 | Iran J Kidney Dis | Epidemiologic Association of Nonalcoholic Fatty Liver Disease and Urinary Calculi: a Population-based Cross-sectional Study in Southern China. | 2018 | Details |
| A14247 | 29507217 | Proc Natl Acad Sci U S A | High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism. | 2018 | Details |
| A14248 | 29507043 | J Endocrinol | Lactobacillus acidophilus NS1 attenuates diet-induced obesity and fatty liver. | 2018 | Details |
| A14249 | 29506157 | J Clin Endocrinol Metab | Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose. | 2018 | Details |
| A14250 | 29505790 | Biochem Biophys Res Commun | Berberine alleviates hepatic lipid accumulation by increasing ABCA1 through the protein kinase C δ pathway. | 2018 | Details |
| A14251 | 29505553 | J Clin Gastroenterol | Prediction of Liver Steatosis Applying a New Score in Subjects from the Brazilian Longitudinal Study of Adult Health. | 2020 | Details |
| A14252 | 29505475 | Eur J Gastroenterol Hepatol | De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients. | 2018 | Details |
| A14253 | 29504312 | J Zhejiang Univ Sci B | Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders. | 2018 | Details |
| A14254 | 29503789 | Curr Hepatol Rep | Managing the Burden of Non-NASH NAFLD. | 2017 | Details |
| A14255 | 29503733 | BMJ Open Gastroenterol | Clinicopathological and immunological characteristics and outcome of concomitant coeliac disease and non-alcoholic fatty liver disease in adults: a large prospective longitudinal study. | 2018 | Details |
| A14258 | 29499974 | Trends Pharmacol Sci | Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution. | 2018 | Details |
| A14259 | 29499310 | Neurosci Lett | Spirulina maxima extract prevents cell death through BDNF activation against amyloid beta 1-42 (Aβ1-42) induced neurotoxicity in PC12 cells. | 2018 | Details |
| A14260 | 29498345 | Br J Nutr | 20-Week follow-up of hepatic steatosis installation and liver mitochondrial structure and activity and their interrelation in rats fed a high-fat-high-fructose diet. | 2018 | Details |
| A14261 | 29497783 | Diabetologia | Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents. | 2018 | Details |
| A14262 | 29497497 | F1000Res | The role of NAFLD in cardiometabolic disease: an update. | 2018 | Details |
| A14263 | 29496501 | Am J Med | Geographic Variability in Liver Disease-Related Mortality Rates in the United States. | 2018 | Details |
| A14264 | 29495113 | Liver Int | Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy. | 2018 | Details |
| A14265 | 29494209 | Am J Physiol Gastrointest Liver Physiol | Biliverdin reductase and bilirubin in hepatic disease. | 2018 | Details |
| A14266 | 29493856 | Liver Int | Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non-alcoholic fatty liver disease. | 2018 | Details |
| A14267 | 29493093 | HIV Med | Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0. | 2018 | Details |
| A14268 | 29492830 | Clin J Gastroenterol | The genetic backgrounds in nonalcoholic fatty liver disease. | 2018 | Details |
| A14269 | 29491288 | Intern Med | A Patient with Non-alcoholic Steatohepatitis Complicated by Multiple Myeloma. | 2018 | Details |
| A14270 | 29491146 | J Biol Chem | Mice lacking ARV1 have reduced signs of metabolic syndrome and non-alcoholic fatty liver disease. | 2018 | Details |
| A14271 | 29489647 | Medicine (Baltimore) | Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi, China. | 2018 | Details |
| A14272 | 29489643 | Medicine (Baltimore) | Wet beriberi with multiple organ failure remarkably reversed by thiamine administration: A case report and literature review. | 2018 | Details |
| A14273 | 29488637 | Lipids | Human Liver Fatty Acid Binding Protein-1 T94A Variant, Nonalcohol Fatty Liver Disease, and Hepatic Endocannabinoid System. | 2018 | Details |
| A14274 | 29488485 | Ter Arkh | [Nonalcoholic fatty liver disease without obesity: the problem to be solved]. | 2019 | Details |
| A14275 | 29488482 | Ter Arkh | [Optimization of therapy for hepatobiliary disorders in psoriatic patients]. | 2019 | Details |
| A14276 | 29487372 | Sci Rep | Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy. | 2018 | Details |
| A14277 | 29487137 | Genetics | Seven-Up Is a Novel Regulator of Insulin Signaling. | 2018 | Details |
| A14278 | 29486327 | Biochim Biophys Acta Mol Cell Biol Lipids | FTO promotes SREBP1c maturation and enhances CIDEC transcription during lipid accumulation in HepG2 cells. | 2018 | Details |
| A14279 | 29486218 | Toxicology | Cadmium exposure exacerbates hyperlipidemia in cholesterol-overloaded hepatocytes via autophagy dysregulation. | 2018 | Details |
| A14280 | 29485130 | Am J Gastroenterol | The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth. | 2018 | Details |